# Follow-up of Myocardial T1 Relaxation Time in Patients With Anderson Fabry Disease

> **NCT02956954** · NA · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 26 (actual)

## Conditions studied

- Anderson-Fabry Disease

## Interventions

- **DRUG:** Enzyme replacement therapy (Agalsidase alpha (Replagal®))
- **PROCEDURE:** Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT02956954
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-25
- **Primary completion:** 2023-01-23
- **Final completion:** 2023-01-23
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02956954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02956954, "Follow-up of Myocardial T1 Relaxation Time in Patients With Anderson Fabry Disease". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02956954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*